Morgan Stanley’s Cingulate CING Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9K Buy
2,400
+1,400
+140% +$8.94K ﹤0.01% 6829
2025
Q4
$4.34K Buy
+1,000
New +$3.86K ﹤0.01% 7095
2023
Q1
Hold
0
-$19 7730
2022
Q4
Hold
0
7775
2022
Q3
Hold
0
7720

Other funds holding CING

Morgan Stanley's CING Position: Q1 2026 in Review

Morgan Stanley increased its Cingulate (CING) stake by 140% in Q1 2026, buying an estimated $8.94K and bringing the position to 2,400 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6829.

Morgan Stanley first reported a position in CING in Q4 2025 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold CING as of Q1 2026.

  • Morgan Stanley held 2,400 shares of Cingulate worth $14.9K as of Q1 2026.
  • Morgan Stanley bought 1,400 Cingulate shares in Q1 2026, an estimated $8.94K.
  • Cingulate made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6829 holding.
  • Morgan Stanley first reported a position in Cingulate in Q4 2025 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Cingulate as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.